Under the agreement, ChemDiv will be initiating a high-throughput screen for small molecule inhibitors of tyrosylprotein sulfotransferases. The collaboration provides Siwa Biotech with access to ChemDiv’s expertise in chemistry systems and lead discovery.
Kevin Moore, president of Siwa Biotech, said: “We are excited to initiate this collaborative discovery project with ChemDiv. The project has an excellent chance of success, based on ChemDiv’s excellent track record in small molecule drug discovery.”